Detalhe da pesquisa
1.
Extracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host Anemia.
Cell
; 164(1-2): 246-257, 2016 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26771494
2.
Tumor and Systemic Immunomodulatory Effects of MEK Inhibition.
Curr Oncol Rep
; 23(2): 23, 2021 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547983
3.
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties.
Breast Cancer Res Treat
; 179(3): 631-642, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31823098
4.
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies.
Breast Cancer Res Treat
; 174(2): 401-412, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30560461
5.
Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy.
Cancer Immunol Res
; 9(10): 1187-1201, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34389557
6.
Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones.
J Clin Invest
; 131(6)2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529175
7.
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.
J Clin Invest
; 131(24)2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34907910
8.
Effects of B cell-activating factor on tumor immunity.
JCI Insight
; 5(10)2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32434989
9.
HoxA9 binds and represses the Cebpa +8 kb enhancer.
PLoS One
; 14(5): e0217604, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31120998
10.
MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity.
PLoS One
; 14(10): e0224600, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31671149
11.
Sending a message: extracellular vesicles of pathogenic protozoan parasites.
Nat Rev Microbiol
; 14(11): 669-675, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27615028